Treatments | Dose (mg/kg) | Â | Behavioural seizure | Â | ||||
---|---|---|---|---|---|---|---|---|
kindling development (day) | Number | Duration (s) | Seizure mean stage | |||||
Myoclonic jerks | Myoclonic jerks latency | Onset of clonic seizures | Latency to generalized clonic-tonic seizures | Duration of generalized clonic-tonic seizures | ||||
Vehicle + Saline | – + – | – | – | – | – | – | – | – |
Vehicle + PTZ | – + 30 | 30.00 ± 1.65 | 64.32 ± 2.45 | 45.45 ± 8.55 | 61.83 ± 8.61 | 185.45 ± 15.55 | 19.48 ± 1.32 | 4.00 ± 0.00 |
IGEFA + PTZ | 15 + 30 | 32.21 ± 2.45 | 28.23 ± 2.14** | 68.54 ± 5.25 | 75.16 ± 7.61 | 252.27 ± 24.14* | 14.12 ± 1.25 | 2.33 ± 0.45* |
IGEFA + PTZ | 30 + 30 | 44.13 ± 2.28* | 18.48 ± 2.13** | 85.48 ± 4.47 | 185.21 ± 9.15*** | 324.15 ± 27.12*** | 8.24 ± 0.16** | 2.16 ± 0.27* |
IGEFA + PTZ | 60 + 30 | 44.36 ± 2.32* | 14.25 ± 2.34** | 126.53 ± 8.15*** | 285.20 ± 7.62*** | 388.22 ± 35.26*** | 4.86 ± 0.24*** | 1.83 ± 0.28** |
IGEFA + PTZ | 90 + 30 | 43.72 ± 2.48* | 8.45 ± 1.22*** | 173.62 ± 9.34*** | 371.52 ± 6.27*** | 495.48 ± 57.41*** | 3.29 ± 0.23*** | 1.33 ± 0.44** |
SVA + PTZ | 300 + 30 | 43.58 ± 2.34** | 7.24 ± 1.56*** | 157.47 ± 8.52*** | 245.57 ± 6.45*** | 582.54 ± 48.36*** | 2.27 ± 0.15*** | 1.16 ± 0.27** |
SVA + Saline | 300 + – | – | – | – | – | – | – | – |
IGEFA + Saline | 90 + – | – | – | – | – | – | – | – |